Maryland has become the first state to implement a Board to address drug costs. The Board is charged with determining potentially unaffordable prescription drugs and making policy recommendations to the General Assembly focused on reducing drug prices. After completing a study of the price of prescription drugs in Maryland, the Board is permitted to draft a plan that recommends a ceiling on the price of prescription drugs purchased by state, county, or municipal government employees.
If the Board decides to make recommendations, the General Assembly must review them and, if it approves the recommendations, it must do so by January The legislature also addressed long-term medication coverage and changes to the drug formulary.
First, the legislation recognizes that individuals who are on long-term medication for chronic conditions may change insurers, and the new insurers often require patients to seek a new authorization in order to receive their medication.
This can often result in patients not being able to get the medication for a period of time. Second, physicians will now be notified when a health insurer removes a drug from its drug formulary or changes the patient to a different prescription drug covered by the drug formulary. OHA continues to promote adoption of their PDMP, and works with health systems, insurers and other partners to increase access to medication assisted treatment and non-pharmaceutical pain care for chronic non-cancer pain.
Skip directly to site content Skip directly to page options Skip directly to A-Z link. Drug Overdose. Section Navigation. Facebook Twitter LinkedIn Syndicate. State Successes. Minus Related Pages. Related Pages. The program includes a multi-disciplinary advisory board which makes recommendations on the design and implementation of the program.
The Board is comprised of state health officials, physicians, pharmacists and law enforcement. Captain Daniel Alioto, Commander of the St.
0コメント